A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Logge, Christoph [1 ]
Vettorazzi, Eik [2 ]
Fischer, Lutz [1 ]
Nashan, Bjoern [1 ]
Sterneck, Martina [1 ]
机构：
[1] Med Univ Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany
[2] Med Univ Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
519
引用
收藏
页码：553A / 553A
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of HCV Treatment Among Liver Transplantation Candidates
    Cholapranee, Aurada
    Leff, Jared A.
    Kinkhabwala, Milan
    Litwin, Alain H.
    Schwartz, Jonathan M.
    Linas, Benjamin P.
    HEPATOLOGY, 2016, 64 : 54A - 55A
  • [2] COST-EFFECTIVENESS OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION
    Vitale, A.
    Spolverato, G.
    Burra, P.
    Cillo, U.
    Fagiuoli, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S301 - S302
  • [3] COST-EFFECTIVENESS OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION
    Vitale, A.
    Spolverato, G.
    Burra, P.
    De Feo, T. M.
    Cillo, U.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E7 - E7
  • [4] Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection
    Logge, Christoph
    Vettorazzi, Eik
    Fischer, Lutz
    Nashan, Bjoern
    Sterneck, Martina
    TRANSPLANT INTERNATIONAL, 2013, 26 (05) : 527 - 534
  • [5] FIBROSIS PROGRESSION AFTER ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION
    De Martin, Eleonora
    Masier, Annalisa
    Senzolo, Marco
    Boninsegna, Sara
    Ponziani, Francesca R.
    Vigano, Raffaella
    Belli, Luca
    Pinzello, Giovambattista
    Colledan, Michele
    Donato, Francesca C.
    Di Paolo, Daniele
    Angelico, Mario
    Rendina, Maria
    Pompili, Maurizio
    Gasbarrini, Antonio
    Russo, Francesco P.
    Cillo, Umberto
    Fagiuoli, Stefano
    Burra, Patrizia
    LIVER TRANSPLANTATION, 2009, 15 (07) : S108 - S108
  • [6] Antiviral treatment in HCV recurrence after liver transplantation in HCV-HIV coinfected patients
    Castells, LL
    Vargas, V
    Len, O
    Bilbao, I
    Margarit, C
    Pahissa, A
    Esteban, JI
    Esteban, R
    Guardia, J
    LIVER TRANSPLANTATION, 2005, 11 (07) : C77 - C77
  • [7] ANTIVIRAL TREATMENT OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION: IMPACT ON COSTS AND QUALITY OF LIFE
    Logge, C.
    Vettorazzi, E.
    Nashan, B.
    Sterneck, M.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 57 - 58
  • [8] ANTIVIRAL TREATMENT OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION: IMPACT ON COSTS AND QUALITY OF LIFE
    Logge, Christoph
    Vettorazzi, Eik
    Nashan, Bjoern
    Sterneck, Martina R.
    HEPATOLOGY, 2010, 52 (04) : 759A - 759A
  • [9] THE COST-EFFECTIVENESS OF HCV ANTIVIRAL TREATMENT FOR INJECTING DRUG USER POPULATIONS
    Martin, N. K.
    Vickerman, P.
    Foster, G. R.
    Miners, A.
    Hutchinson, S. J.
    Goldberg, D. J.
    Hickman, M.
    GUT, 2011, 60 : A25 - A25
  • [10] Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?
    De Martin, Eleonora
    Rodriguez-Castro, Kryssia I.
    Vitale, Alessandro
    Zanus, Giacomo
    Senzolo, Marco
    Russo, Francesco Paolo
    Burra, Patrizia
    FUTURE VIROLOGY, 2011, 6 (10) : 1179 - 1186
12345